Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving blood clotting factor
Reexamination Certificate
2005-08-30
2005-08-30
Gitomer, Ralph (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving blood clotting factor
C435S214000
Reexamination Certificate
active
06936430
ABSTRACT:
Method of detecting coagulation abnormalities in a plasma sample by (a) determining a test rate of thrombin generation over a given time interval by reacting an activator of thrombin with defibrinated normal plasma in the presence of a defibrinated test plasma sample; (b) determining a control rate of thrombin generation over substantially the same time interval in step (a) by reacting the same activator of thrombin with defibrinated normal plasma in the absence of any defibrinated test plasma; and (c) comparing the rates of thrombin generation between test step (a) and control step (b) such that any significant difference between the two thrombin generation rates being indicative of a coagulation abnormality in the test plasma.
REFERENCES:
patent: 5192689 (1993-03-01), Hemker et al.
patent: 5525477 (1996-06-01), Hassouna
patent: 5618713 (1997-04-01), Zettlmeissl et al.
patent: 5705198 (1998-01-01), Triplett et al.
patent: 6429017 (2002-08-01), Toh et al.
patent: 2003/0003515 (2003-01-01), Farrell et al.
patent: 0 420 332 (1991-04-01), None
patent: 2811799 (1998-10-01), None
patent: 1492287 (1989-07-01), None
patent: WO 91/01383 (1991-02-01), None
patent: WO 92/07954 (1992-05-01), None
Rijkers D. et al. Prevention of the Influence of Fibrin and Alpha2-Macroglobulin in the Continuous Measurement of the Thrombin Potential. Thrombosis Research 89(4)161-169, 1998.
Hemker H. et al. Continuous Registration of Thrombin Generation in Plasma, Its Use for the Determination of the Thrombin Potential. Thrombosis and Haemostasis 70(4)617-624, 1993.
Wielders S. et al. the Routine Determination of the Endogenous Thrombin Poteintal, First Results in Different Forms of Hyper and Hypocoagulability. 77(4)629-636, 1997.
Hemker H. et al. Thrombin Generation in Plasma: Its Assessment via the Endogenous Thrombin Potential. Thrombosis and Haemostasis 74(1)134-138, 1995.
Rijkers, D.T.S., et al; “Prevention of the Influence of Fibrin and α2-Macroglobulin in the . . . Endpoint Determination of the Optical Density”; Thrombosis Research, vol. 89, No. 4, 1998, pp. 161-169, XP002917872; ISSN: 0049-3848.
Howie, P.W. et al; “A Method of Antithrombin Estimation using Plasma Defibrinated with Ancrod”; British Journal of Haematology; vol. 25, 1973, pp. 101-110, SP002221488.
Patent Abstracts of Japan; vol. 1995, No. 03; Apr. 28, 1995; & JP 06 331628 A (Sekisui Chem. Co. Ltd. ), Dec. 2, 1994; abstract.
Hemker, H.C. et al; “Continuous Registration of Thrombin Generation in Plasma, Its Use for the Determination of the Thrombin Potential”; Thrombosis and Haemostasis, Stuttgart, DE, vol. 70, No. 4, 1993, pp. 617-624, XP000567560; ISSN: 0340-6245.
Hunt, J.E., et al; “A Phospholipid-β2-Glycoprotein I Complex is an Antigen for Anticardiolipin Antibodies Occuring in Autoimmune Disease But Not with Infection”;Lupus1(2); pp. 75-81 (1992).
Wielders, S., et al; “The Routine Determination of the Endogenous Thrombin Potential, First Results in Different Forms of Hyper-and Hypocoagulability”;Thromb. Haemost.; 77(4); pp. 629-636 (1997).
Forastiero, R.R., et al; “Relationship of Anti β2-glycoprotein I and Anti Prothrombin Antibodies to Thrombosis and Pregnancy Loss in Patients with Antiphospholipid Antibodies”;Thromb. Haemost; 78(3); pp. 1008-1014 (1997).
Schultz, D.R.; “Antiphospholipid Antibodies: Basic Immunology and Assays”;Seminars in Arthritis and Rheumatism; 26(5); pp. 724-739 (1997).
Hemker, H.C., et al; “Thrombin Generation in Plasma: Its Assessment Via the Endogenous Thrombin Potential”;Thromb Haemost.; 74(1); pp. 134-138 (1995).
Derwent Abstract Accession No. 95-054707/08, Class S03; JP 0-6331628 (Sekisui); Dec. 2, 1994.
Gitomer Ralph
Nixon & Vanderhye
South Eastern Sydney Area Health Service
LandOfFree
Procoagulant assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Procoagulant assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Procoagulant assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3521206